RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3-[4-methylphenyl and 4-chlorophenyl]-2-[5-(substituted phenyl)thiazol-2-yl]tropanes
Gong, PK., Blough, B., Brieaddy, L., Huang, X., Kuhar, MJ., Navarro, H., & Carroll, F. (2007). Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3-[4-methylphenyl and 4-chlorophenyl]-2-[5-(substituted phenyl)thiazol-2-yl]tropanes. Journal of Medicinal Chemistry, 50(15), 3686-3695. https://doi.org/10.1021/jm0703035 S0022-2623(07)00303-2
Synthetic methods were developed for the synthesis of the 3-(4-substituted phenyl)-2-[5-(substituted phenyl)thiazol-2-yl]tropanes (4a-s). The compounds were evaluated for their monoamine transporter binding and monoamine uptake inhibition properties using both rat brain tissue and cloned transporter assays. In general, the compounds showed higher dopamine transporter (DAT) affinity relative to the serotonin and norepinephrine transporters (SERT and NET, respectively) and greater [3H]dopamine uptake inhibition potency relative to [3H]serotonin and [3H]norepinephrine uptake inhibition. Several compounds were DAT selective relative to the SERT and NET in the monoamine transporter binding assays. The most potent and selective analog in the functional monoamine uptake inhibition test was 3-(4-methylphenyl-2-[5-(3-nitrophenyl)thiazol-2-yl]tropane (4p).
